These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4875752)

  • 1. Hypotensive action of bretylium after central administration.
    Jaju BP; Tangri KK; Bhargava KP
    Can J Physiol Pharmacol; 1968 Jul; 46(4):687-9. PubMed ID: 4875752
    [No Abstract]   [Full Text] [Related]  

  • 2. Central vasomotor effects of alpha-methyl dopa.
    Jaju BP; Tangri KK; Bhargava KP
    Can J Physiol Pharmacol; 1966 Jul; 44(4):687-90. PubMed ID: 5966573
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of halothane on peripheral and central vasomotor control mechanisms of the dog.
    Wang HH; Epstein RA; Markee SJ; Bartelstone HJ
    Anesthesiology; 1968; 29(5):877-86. PubMed ID: 5673146
    [No Abstract]   [Full Text] [Related]  

  • 4. Profound hypotension and abolition of the vasomotor component of the cerebral ischemic response produced by restricted lesions of medulla oblongata in rabbit. Relationship to the so-called tonic vasomotor center.
    Kumada M; Dampney RA; Reis DJ
    Circ Res; 1979 Jul; 45(1):63-70. PubMed ID: 445699
    [No Abstract]   [Full Text] [Related]  

  • 5. Actions of angiotensin on the central nervous system.
    Buckley JP
    Fed Proc; 1972; 31(4):1332-7. PubMed ID: 4402612
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of a cholinesterase inhibitor when injected into the medulla of the rabbit.
    Stewart WC; Anderson EA
    J Pharmacol Exp Ther; 1968 Aug; 162(2):309-18. PubMed ID: 4875330
    [No Abstract]   [Full Text] [Related]  

  • 7. DEPRESSION OF THE VASOMOTOR CENTRE BY MECAMYLAMINE, INDEPENDENT OF ITS GANGLION-BLOCKING ACTIVITY.
    BHARGAVA KP; DHAWAN KN
    Br J Pharmacol Chemother; 1963 Aug; 21(1):39-44. PubMed ID: 14066149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of halothane on circulatory reflexes of the dog.
    Epstein RA; Wang HH; Bartelstone HJ
    Anesthesiology; 1968; 29(5):867-76. PubMed ID: 5673145
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of acetylcholine in central vasomotor regulation.
    Sinha JN; Dhawan KN; Chandra O; Gupta GP
    Can J Physiol Pharmacol; 1967 May; 45(3):503-7. PubMed ID: 6035169
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular effects of angiotensin mediated by the central nervous system.
    Ferrario CM; Gildenberg PL; McCubbin JW
    Circ Res; 1972 Mar; 30(3):257-62. PubMed ID: 4334162
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous pressure monitoring in experimental obstructive hydrocephalus. II. The origin of undulating ventricular waves and periodic respirations.
    Obenchain TG; Stern WE
    Arch Neurol; 1973 Nov; 29(5):295-8. PubMed ID: 4200634
    [No Abstract]   [Full Text] [Related]  

  • 12. An analysis of the central vasomotor effects of monoamine oxidase inhibitor, modaline sulphate.
    Tangri KK; Dhasmana KM; Dixit KS
    Jpn J Pharmacol; 1972 Oct; 22(5):599-604. PubMed ID: 4539779
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of the central vasomotor effects of (-)-N-(1-phenylethyl)guanidine, a new adrenergic neuron blocking agent.
    Bapat SK; Dhawan BN; Srimal RC
    Can J Physiol Pharmacol; 1969 Aug; 47(8):725-9. PubMed ID: 5820115
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of bretylium and guanethidine: tolerance, and effects on adrenergic nerve function and responses to sympathomimetic amines.
    BOURA AL; GREEN AF
    Br J Pharmacol Chemother; 1962 Aug; 19(1):13-41. PubMed ID: 13871863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of central sympathetic excitation and inhibition on the nictitating membrane of the cat.
    Molnár J; György L; Unyi G
    Acta Physiol Acad Sci Hung; 1969; 36(1):137-55. PubMed ID: 5378639
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypotensive activity of several quinoline derivatives.
    Jandhyala BS; Grega GJ; Buckley JP
    Arch Int Pharmacodyn Ther; 1967 May; 167(1):217-26. PubMed ID: 6035099
    [No Abstract]   [Full Text] [Related]  

  • 17. The central vasomotor effects of 5-hydroxytryptamie.
    BHARGAVA KP; TANGRI KK
    Br J Pharmacol Chemother; 1959 Dec; 14(4):411-4. PubMed ID: 13800344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brainstem sites for activation of vagal cardioaccelerator fibers in the dog.
    Weiss GK; Priola DV
    Am J Physiol; 1972 Aug; 223(2):300-4. PubMed ID: 4340011
    [No Abstract]   [Full Text] [Related]  

  • 19. Catecholamine stores under vagal control.
    Vassalle M; Mandel WJ; Holder MS
    Am J Physiol; 1970 Jan; 218(1):115-23. PubMed ID: 4983000
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of the sympathetic-adrenal system in the pathogenesis of essential arterial hypertension].
    Manasia M; Spânu C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(6):481-8. PubMed ID: 6152066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.